Specialty
Certifications
Hematology
American Board of Internal Medicine
Education
MD, New York University School of Medicine
Residency, Internal Medicine
Montreal General HospitalResidency, Internal Medicine
Stanford University School of MedicineFellowship, Hematology
Mount Sinai Hospital
Clinical Trials
- A multi-center, open label phase I/II study of CEP-701 (lestaurtinib) in adults with myelofibrosis
- A Phase 1/2 Multiple Ascending Dose Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BMS-911543 in Subjects with Myelofibrosis
- Randomized Trial of Pegylated Interferon Alfa-2a versus Hydroxurea Therapy in the Treatment of High Risk Polycythemia Vera and High Risk Essential Thrombocythemia
- MPD-RC 111: Single Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High Risk PV or High Risk ET who are Either Hydroxurea Resistent or Intolerant or Have Had Abdominal Vein Thrombosis
- A Phase 2 trial to evaluate the activity of Imetelstat (GRN136L) in patients with essential thrombocythemia who require Cytoreduction and have failed or are intolerant to previous therapy, or who refuse standard therapy
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Hoffman during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- AllCells, LLC; Bristol-Myers Squibb; Forest Research Institute Inc (Forest Laboratories, Inc); Incyte Corporation
Scientific Advisory Board:
- AllCells, LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Tisch Cancer Institute; Atran Berg Laboratory Building
1428 Madison Avenue, E Level, Box 1079
New York, NY 10029
Fax: 212-876-5276
1470 Madison Avenue
New York, NY 10029
